Mar 1, 2015

TTIP: Microtechnology companies welcome reduction of trade barriers but criticize IP and investment protection

Mar 1, 2015



TTIP: Microtechnology companies criticize IP and investment protection
 
The possible benefits of the Transatlantic Trade and Investment Partnership (TTIP) most often mentioned by the European microtechnology companies are an elimination of tariffs and a reduction of administrative barriers. SME that have already entered the US market are more often looking forward to more transparent import regulations, easier access to orders as well as a better protection of Intellectual Property rights and investments in the US than those without US market activities.
 
IP and investment protection, however, are also issues that make the industry doubt the all-over benefit of TTIP for European high-tech SME. The companies are especially bothered by the differences in the patent laws of the US and Europe, which would put European companies at a disadvantage, and the uncertainties concerning investment protection – a topic which is still waiting to be negotiated.
 
Source: IVAM Survey 2015

Recommended articles

Dec 16, 2024

The NEPOMUQ research project, a collaboration between AMO GmbH and the University of Wuppertal, focuses on the development of integrated …

Dec 13, 2024

This holiday season, we celebrate the joy that comes from working together. Across the globe, our shared commitment to innovation …

Dec 3, 2024

COMPAMED 2024 once again consolidated its position as the leading international trade fair for medical technology supplies. The IVAM joint …

Recommended events

Sep 9 - 11, 2026
Manufacturing Processes for Medical Technology
Nov 17 - 20, 2025
Product Market “High-tech for Medical Devices”: A hub for high-tech solutions and medical innovations. Team up with IVAM to pave your way to trade fair success!
Sep 10 - 12, 2025
Special Exhibiting Area ‘’Manufacturing Processes and Components for Medical Technology’’